Literature DB >> 17493053

Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction.

Despina A Tata1, Bryan K Yamamoto.   

Abstract

AIMS: Methamphetamine is an amphetamine derivative that is abused increasingly world-wide at an alarming rate over the last decade. Pre-clinical and human studies have shown that methamphetamine is neurotoxic to brain dopamine and serotonin. Other lines of study indicate that stress enhances the vulnerability to drug abuse. The purpose of this review is to shed light on the biochemical similarities between methamphetamine and stress in an effort to highlight the possibility that prior exposure to stress may interact with methamphetamine to exacerbate neurotoxicity.
METHODS: A review of the literature on methamphetamine and stress was conducted that focused on the common neurotoxic and biochemical consequences of methamphetamine administration and stress exposure.
RESULTS: Experimental findings of a large number of studies suggest that there are parallels between stress and methamphetamine with regard to their ability to increase glutamate release, produce a metabolic compromise and cause oxidative damage.
CONCLUSION: A combination of methamphetamine administration and stress can act synergistically and/or additively to cause or augment toxicity in brain regions such as striatum and hippocampus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493053     DOI: 10.1111/j.1360-0443.2007.01770.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  46 in total

1.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

Review 2.  Modulation of intracellular restriction factors contributes to methamphetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages.

Authors:  Xu Wang; Yizhong Wang; Li Ye; Jieliang Li; Yu Zhou; Sinem Sakarcan; Wenzhe Ho
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 3.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

4.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

5.  Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Neuropharmacology       Date:  2015-01-31       Impact factor: 5.250

6.  Adding fuel to the fire: methamphetamine enhances HIV infection.

Authors:  Raghava Potula; Yuri Persidsky
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

7.  mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.

Authors:  Justin T Gass; Megan P H Osborne; Noreen L Watson; Jordan L Brown; M Foster Olive
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

8.  Oxidative stress from diverse developmental neurotoxicants: antioxidants protect against lipid peroxidation without preventing cell loss.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2009-12-11       Impact factor: 3.763

Review 9.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

Authors:  Chris Derauf; Barry M Lester; Nurunisa Neyzi; Minal Kekatpure; Luis Gracia; James Davis; Kalpana Kallianpur; Jimmy T Efird; Barry Kosofsky
Journal:  Dev Neurosci       Date:  2012-08-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.